Rolf F Barth
机构: Professor of Pathology, The Ohio State University
每年引用次数
引用次数
引用: 19,450
H-指数: 67
I10-指数 : 234
出版物: 517
A new radioisotopic microcytotoxicity assay of cellular immunity utilizing technetium-99m.
Gillespie Gy rd , Barth Rf , Gobuty A
National Cancer Institute monograph 35 39 -41
3
1972
Labeling of mammalian nucleated cells with 99mTc.
Gobuty A , Barth Rf , Gillespie Gy
The Journal of Nuclear Medicine 14 ( 9) 706 -708
16
1973
Boron chemistry and target cell affinity.
Bapat Bv , Barth Rf , Soloway Ah , Alam F
Strahlentherapie Und Onkologie 165 118 -120
9
1989
Radioimmunoguided surgery: intraoperative use of monoclonal antibody 17-1A in colorectal cancer.
Goodwin Ra , Barth Rf , Oredipe Oa , Martin Ew
Hybridoma
24
1986
In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy.
Rotaru Jh , Wyzlic Im , Barth Rf , Soloway Ah
Anticancer Research 15 2033 -2038
15
1995
Corticosteroids and leukocyte blastogenesis in renal transplantation.
Barth Rf , Thomas Jh , Pierce Ge , Vessella Rl
Transplantation proceedings 11 ( 1) 364 -369
1
1979
Effects of antilymphocyte sera on antibody forming cells and macrophages in the early immune response.
Hunter Rl , Southworth J , Barth Rf
Transplantation proceedings 1 ( 1) 433
2
1969
Enhanced survival in a rat glioma model following BNCT.
NR Clendenon , Rolf Frederick Barth , JH Goodman , AE Staubus
Strahlentherapie Und Onkologie 165 222
4
1989
Studies on the phenotypic expression of histocompatibility antigens on cell surfaces by means of the mixed hemadsorption reaction.
Espmark Ja , Barth Rf , Fagraeus A
The Wistar Institute symposium monograph 8 105 -119
1968
Critical evaluation of bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors.
Barth Rf , Soloway Ah , Adams Dm , Liu L
Anticancer Research 16 2581 -2587
29
1996
Chemopreventative activity of dietary glucarate on azoxymethane-induced altered hepatic foci in rats.
Oredipe Oa , Barth Rf , Webb Te , Dwivedi C
Research communications in chemical pathology and pharmacology 65 ( 3) 345 -359
3
1989
Neutron capture using boronated monoclonal antibody directed against tumor-associated antigens.
Wei Wz , Carey We , Johnson Cw , McGuire J
Cancer Detection and Prevention 5 ( 3) 315 -323
21
1982
Conjugation, purification and characterization of boronated monoclonal antibodies for use in neutron capture therapy.
Mafune N , Steplewski Z , Barth Rf , Soloway Ah
Strahlentherapie Und Onkologie 165 142
27
1989
Excess lipofuscin accumulation in constitutional hepatic dysfunction (Gilbert's syndrome). Light and electron microscopic observations.
Barth Rf , Grimley Pm , Bloomer , Howe Rb
Archives of pathology 91 ( 1) 41
14
1971
Antigenic cross-reactivity between human leukemic cells and dinitrophenylated normal leukocytes.
Barth Rf , Madyastha Pr , Madyastha Kr
Experimental Hematology 11 ( 5) 371 -381
1983
Evaluation of in vitro cytotoxicity of carboranyl amino acids, their chemical precursors and nido carboranyl amino acids for boron neutron capture therapy.
Rotaru Jh , Wyzlic Im , Barth Rf , Soloway Ah
Anticancer Research 15 2039 -2043
18
1995
Boronated monoclonal antibody 17-1A for potential neutron capture therapy of colorectal cancer.
Steplewski Z , Barth Rf , Soloway Ah , Alam F
Hybridoma
12
1986
Mitogen- and alloantigen-stimulated blastogenic responses of dinitrophenyl-modified human lymphocytes.
R. F. Barth , S. N. Chen , J. L. Winklehake , J. J. O'Hara
Immunology 47 ( 3) 511
1
1982
Monoclonal antibodies to dimethylbenzanthracene (dmba) induced murine mammary tumors. Abstr.
W. Z. Wei , R. F. Barth , C. W. Johnson
Federation Proceedings 41 ( 3) 595
1982
In vitro and in vivo evaluation of carboranyl uridines as boron delivery agents for neutron capture therapy.
W. Tjarks , R. F. Barth , A. H. Soloway , A. K. M. Anisuzzaman
Anticancer Research 16 ( 1) 113 -120
8
1996